SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-11-031190
Filing Date
2011-05-19
Accepted
2011-05-19 17:10:20
Documents
1
Period of Report
2011-05-18

Document Format Files

Seq Description Document Type Size
1 v223521_ex.html 4  
1 v223521_ex.xml 4 4691
  Complete submission text file 0001144204-11-031190.txt   6362
Mailing Address C/O AEOLUS PHARMACEUTICALS, INC. 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address
McManus John L (Reporting) CIK: 0001193923 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50481 | Film No.: 11858706

Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001261734 (see all company filings)

IRS No.: 561953785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations